Jufeng Guo

机构：Westlake University, Hangzhou First People's Hospital · ORCID：0000-0001-5341-0271

发表论文 44 篇 · 总被引 996 次 · h-index 19

代表论文

• Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF-β degradation (2022 · Nature Communications · 被引 108)
• Crosstalk between cancer-associated fibroblasts and regulated cell death in tumors: insights into apoptosis, autophagy, ferroptosis, and pyroptosis (2024 · Cell Death Discovery · 被引 64)
• Serum Exosome-Derived piRNAs Could Be Promising Biomarkers for HCC Diagnosis (2023 · International Journal of Nanomedicine · 被引 48)
• Serum-Exosome-Derived miRNAs Serve as Promising Biomarkers for HCC Diagnosis (2022 · Cancers · 被引 40)
• Mitophagy: insights into its signaling molecules, biological functions, and therapeutic potential in breast cancer (2024 · Cell Death Discovery · 被引 38)
• Targeting pyroptosis in breast cancer: biological functions and therapeutic potentials on It (2023 · Cell Death Discovery · 被引 33)